Electromed (ELMD) Change in Account Payables (2021 - 2023)
Electromed's (ELMD) quarterly Change in Account Payables came in at -$349000.0 in Q1 2023, down 353.25% year-on-year from $137810.3 in Q1 2022, and down 237.4% on a QoQ basis from $254000.0 in Q4 2022.
Electromed (ELMD) Change in Account Payables (2021 - 2023) Analysis & Trends
Electromed (ELMD) has 3 years of Change in Account Payables data on file, last reported at -$349000.0 in Q1 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | - |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | -198.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | - |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | - |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | - |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 221.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Electromed | 313.26 Mn | 296.27 Mn | 14.64 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2023 | -349,000.00 |
| Mar 31, 2023 | -349,000.00 |
| Dec 31, 2022 | 254,000.00 |
| Dec 31, 2022 | 254,000.00 |
| Sep 30, 2022 | -175,000.00 |
| Sep 30, 2022 | -175,000.00 |
| Mar 31, 2022 | -77,000.00 |
| Mar 31, 2022 | -77,000.00 |
| Dec 31, 2021 | 132,000.00 |
| Dec 31, 2021 | 132,000.00 |
| Sep 30, 2021 | -498,000.00 |
| Sep 30, 2021 | -498,000.00 |